BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 17617518)

  • 1. Role of surgery in ovarian carcinoma.
    Fader AN; Rose PG
    J Clin Oncol; 2007 Jul; 25(20):2873-83. PubMed ID: 17617518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.
    Tebes SJ; Sayer RA; Palmer JM; Tebes CC; Martino MA; Hoffman MS
    Gynecol Oncol; 2007 Sep; 106(3):482-7. PubMed ID: 17590420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colon resection for ovarian cancer: intraoperative decisions.
    Hoffman MS; Zervose E
    Gynecol Oncol; 2008 Nov; 111(2 Suppl):S56-65. PubMed ID: 18835022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of secondary cytoreductive surgery in epithelial ovarian malignancies.
    Williams L
    Oncology (Williston Park); 1992 Aug; 6(8):25-32; discussion 37-9. PubMed ID: 1386995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current surgical management in ovarian cancer recurrences].
    Tinelli FG; Tinelli A; Campagnutta E; Kobal B; Rakar S; Manca C; Tinelli R; Perrone A
    Minerva Ginecol; 2004 Oct; 56(5):457-67. PubMed ID: 15531862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer.
    Munkarah A; Levenback C; Wolf JK; Bodurka-Bevers D; Tortolero-Luna G; Morris RT; Gershenson DM
    Gynecol Oncol; 2001 May; 81(2):237-41. PubMed ID: 11330956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoreductive surgery combined with organ resection for advanced ovarian carcinoma.
    Todo Y; Sakuragi N; Oikawa M; Negishi H; Yamamoto R; Yoshiaki K; Tsumura N; Kawaguchi I; Fujimoto S
    Int J Clin Oncol; 2003 Apr; 8(2):90-6. PubMed ID: 12720101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: a Gynecologic Oncology Group Study.
    Williams L; Brunetto VL; Yordan E; DiSaia PJ; Creasman WT
    Gynecol Oncol; 1997 Aug; 66(2):171-8. PubMed ID: 9264559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery of advanced malignant epithelial tumours of the ovary.
    Favalli G; Odicino F; Pecorelli S
    Forum (Genova); 2000; 10(4):312-20. PubMed ID: 11535982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How to increase the optimal rate of secondary cytoreductive surgery in recurrent epithelial ovarian cancer].
    Li YF; Li MD; Liu FY; Liu JH; Li JD
    Ai Zheng; 2003 Nov; 22(11):1193-6. PubMed ID: 14613651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent ovarian carcinoma of low malignant potential: the role of secondary surgical cytoreduction and the prognosis in Chinese patients.
    Zang RY; Yang WT; Shi DR; Xing Y; Cai SM
    J Surg Oncol; 2005 Jul; 91(1):67-72. PubMed ID: 15999350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The surgical management of women with ovarian cancer in the south west of England.
    Olaitan A; Weeks J; Mocroft A; Smith J; Howe K; Murdoch J
    Br J Cancer; 2001 Dec; 85(12):1824-30. PubMed ID: 11747321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenectomy during secondary cytoreduction for ovarian cancer disease recurrence: surgical and survival data.
    Manci N; Bellati F; Muzii L; Calcagno M; Alon SA; Pernice M; Angioli R; Panici PB
    Ann Surg Oncol; 2006 Dec; 13(12):1717-23. PubMed ID: 16957965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenectomy as part of cytoreductive surgery in ovarian cancer.
    Magtibay PM; Adams PB; Silverman MB; Cha SS; Podratz KC
    Gynecol Oncol; 2006 Aug; 102(2):369-74. PubMed ID: 16631919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical evaluation of secondary cytoreduction in recurrent ovarian cancer.
    Munkarah AR; Coleman RL
    Gynecol Oncol; 2004 Nov; 95(2):273-80. PubMed ID: 15491746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoreductive surgery and ovarian carcinoma.
    Balbi G; Monteverde A; Landino I; Manganaro MA; Franzese C
    Acta Biomed; 2009; 80(3):230-3. PubMed ID: 20578416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC).
    Cheng X; Jiang R; Li ZT; Tang J; Cai SM; Zhang ZY; Tian WJ; Zang RY
    Eur J Surg Oncol; 2009 Oct; 35(10):1105-8. PubMed ID: 19443175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.
    Fotiou S; Aliki T; Petros Z; Ioanna S; Konstantinos V; Vasiliki M; George C
    Gynecol Oncol; 2009 Aug; 114(2):178-82. PubMed ID: 19450872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery for recurrent ovarian cancer.
    Rose PG
    Semin Oncol; 2000 Jun; 27(3 Suppl 7):17-23. PubMed ID: 10952122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of hand-assisted laparoscopy in ovarian cancer.
    Krivak TC; Elkas JC; Rose GS; Sundborg M; Winter WE; Carlson J; MacKoul PJ
    Gynecol Oncol; 2005 Jan; 96(1):72-6. PubMed ID: 15589583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.